11.53
Schrodinger Inc stock is traded at $11.53, with a volume of 1.28M.
It is down -3.03% in the last 24 hours and down -29.35% over the past month.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$11.89
Open:
$11.69
24h Volume:
1.28M
Relative Volume:
1.13
Market Cap:
$849.35M
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-4.7061
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
+1.14%
1M Performance:
-29.35%
6M Performance:
-40.44%
1Y Performance:
-51.96%
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SDGR
Schrodinger Inc
|
11.53 | 875.87M | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
180.31 | 30.01B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
58.37 | 10.67B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
41.06 | 7.36B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.89 | 6.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.07 | 4.93B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Fidelity
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Schrodinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Schrodinger (NASDAQ:SDGR) Reaches New 52-Week LowShould You Sell? - MarketBeat
Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking A 123% Potential Upside - DirectorsTalk Interviews
How (SDGR) Movements Inform Risk Allocation Models - Stock Traders Daily
Schrodinger (NASDAQ:SDGR) EVP Sells $12,700.25 in Stock - MarketBeat
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - marketscreener.com
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com Canada
Press Release: Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - 富途牛牛
Schrodinger (NASDAQ:SDGR) Insider Sells $16,617.30 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Reaches New 12-Month LowWhat's Next? - MarketBeat
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - pharmiweb.com
Schrodinger stock hits 52-week low at 12.8 USD - Investing.com
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Trading Systems Reacting to (SDGR) Volatility - Stock Traders Daily
With A 26% Price Drop For Schrödinger, Inc. (NASDAQ:SDGR) You'll Still Get What You Pay For - simplywall.st
Schrodinger stock hits 52-week low at 13.43 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Hits New 12-Month LowShould You Sell? - MarketBeat
Schrodinger stock hits 52-week low at 13.43 USD - Investing.com
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth - DirectorsTalk Interviews
TruBridge (TBRG) Surges 5.6%: Is This an Indication of Further Gains? - Nasdaq
Schrodinger (NASDAQ:SDGR) Upgraded at Wall Street Zen - MarketBeat
Is Schrödinger Inc. stock a good dividend stock2025 Historical Comparison & Weekly Stock Performance Updates - mfd.ru
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Schrodinger Inc stock hits 52-week low at $15.97 By Investing.com - Investing.com Nigeria
Schrodinger Inc stock hits 52-week low at $15.97 - Investing.com
How Schrodinger Inc. (SDGR) Affects Rotational Strategy Timing - Stock Traders Daily
Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR - MarketBeat
86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ:SDGR) Shares Down 5.2%Time to Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $91.37 Million Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
(SDGR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Schrödinger Inc. stock could be next big winnerMarket Performance Report & Low Risk Entry Point Guides - Bộ Nội Vụ
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities By Investing.com - Investing.com South Africa
Assessing Schrödinger (SDGR) Valuation After Recent Uneven Share Price Momentum - Yahoo Finance
Schrödinger partners with Lilly TuneLab on AI drug discovery - Drug Target Review
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities - Investing.com Australia
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - BioSpace
Schrödinger outlines 2026 priorities after strong 2025 By Investing.com - Investing.com Nigeria
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lorton Kenneth Patrick | EVP, CTO & COO, Software |
Feb 10 '26 |
Sale |
13.73 |
925 |
12,704 |
52,651 |
| Herman Jenny | CAO |
Feb 10 '26 |
Sale |
13.79 |
752 |
10,370 |
26,597 |
| Abel Robert Lorne | See Remarks |
Feb 09 '26 |
Sale |
13.51 |
1,230 |
16,617 |
19,385 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):